---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-215541"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2025-09-24T23:59:59+00:00"
generated_at: "2026-05-17T05:48:33.780475+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Invivyd appoints Paul B. Bolno, M.D. to board; regains Nasdaq compliance

## Summary
- Dr. Bolno, President and CEO of Wave Life Sciences, appointed to Board and Compensation Committee effective September 22, 2025.
- He receives $40,000 annual cash retainer, $5,000 for committee service, and 100,000 stock options vesting over three years.
- Christine Akinc resigned from Board and all committees on September 22; departure not due to any disagreement.
- Nasdaq notified Invivyd on September 22 that it regained compliance with the $1.00 minimum bid price requirement, closing the matter.

## SEC filing metadata
- accession: 0001193125-25-215541
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2025-09-24T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/0001193125-25-215541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/ivvd-20250922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-215541
- JSON: https://secwatch.observer/filing/0001193125-25-215541.json
- Plain text: https://secwatch.observer/filing/0001193125-25-215541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.